US HB6717 | 2017-2018 | 115th Congress
Status
Sponsorship: Partisan Bill (Democrat 1)
Status: Introduced on September 6 2018 - 25% progression, died in committee
Action: 2018-09-06 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 6 2018 - 25% progression, died in committee
Action: 2018-09-06 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Depression Side Effect Labeling Awareness Act of 2018
Title
Depression Side Effect Labeling Awareness Act of 2018
Sponsors
| Rep. Bobby Rush [D-IL] |
History
| Date | Chamber | Action |
|---|---|---|
| 2018-09-06 | House | Referred to the House Committee on Energy and Commerce. |
| 2018-09-06 | House | Introduced in House |
Subjects
Administrative law and regulatory procedures
Consumer affairs
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Health
Mental health
Consumer affairs
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Health
Mental health
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/115th-congress/house-bill/6717/all-info |
| Text | https://www.congress.gov/115/bills/hr6717/BILLS-115hr6717ih.pdf |
